Category diabetes drugs

Actraphane - insulin
diabetes drugs

Actraphane - insulin

Characteristics of the medicinal product Actraphane is a series of injectable insulin suspensions. Actraphane is available in vials, cartridges (Penfill) or pre-filled pens (NovoLet, FlexPen or InnoLet). The active substance in Actraphane is human insulin (DNAr). Actraphane is a mixture of fast-acting (soluble) insulin and long-acting insulin (isophane)

Read More
diabetes drugs

Avandia - rosiglitazone

Commercialization suspended in the European market What is Avandia? Avandia is a medicine that contains the active substance rosiglitazone. It comes in the form of tablets (pink 2 mg, orange 4 mg or red-brown 8 mg). What is Avandia used for? Avandia is used in adult patients (especially if overweight) with type 2 diabetes (non-insulin-dependent diabetes
Read More
diabetes drugs

AVANDIA ® - Rosiglitazone

AVANDIA ® a drug based on Rosiglitazone. THERAPEUTIC GROUP: Oral hypoglycemic agents - Thiazolidinediones IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications AVANDIA ® - Rosiglitazone AVANDIA ® is a hypoglycemic drug used in the treatment of type II diabetes, not adequately compensated by non-pharmacological therapeutic measures such as diet and physical activity. T
Read More
diabetes drugs

Avandamet

Commercialization suspended in the European market What is that ? Avandamet is a medicine containing two active substances, rosiglitazone and metformin hydrochloride. It is available as tablets (yellow: 1 mg of rosiglitazone and 500 mg of metformin hydrochloride as well as 2 mg of rosiglitazone and 1000 mg of metformin hydrochloride; pale pink: 2 mg of rosiglitazone and 500 mg of metformin hydrochloride; pink: 4 mg of rosiglitazone and 1000 mg of metformin hydrochloride)
Read More
diabetes drugs

Biguanides and metformin

Oral hypoglycemic drugs of the biguanide class Biguanides are oral hypoglycemic drugs that can reduce blood glucose even in the absence of pancreatic cell function B. Phenformin (a biguanide) was removed from the US market due to the high incidence of lactic acidosis. In 1995 metformin was introduced, which is a less toxic biguanide
Read More
diabetes drugs

BI-EUGLUCON ® - Fenformin + Glibenclamide

BI-EUGLUCON ® a drug based on phenformin hydrochloride and glibenclamide THERAPEUTIC GROUP: Oral hypoglycemic agents - combined therapy IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications BI-EUGLUCON ® - Fenformin + Glibenclamide BI-EUGLUCON ® is used in the treatment of second type diabetes mellitus, in case of reduced efficacy of sulfonylureas monotherapy and marked insulin resistance. M
Read More
diabetes drugs

Bydureon - exenatide

What is Bydureon - exenatide? Bydureon is a medicine that contains the active substance exenatide. It is available as a powder and solvent for prolonged release suspension for injection (2 mg exenatide). The term "extended release" means that the active ingredient is released slowly over a few weeks after the injection
Read More
diabetes drugs

Byetta - exenatide

What is Byetta? Byetta is a solution for injection that contains the active substance exenatide. It is available in pre-filled pens ready for use with 5 or 10 micrograms of exenatide per dose. What is Byetta used for? Byetta is indicated for the treatment of type 2 diabetes in combination with other antidiabetic medicines (metformin and / or sulphonylurea) in patients whose blood glucose (sugar) levels are not adequately controlled with the maximum tolerated dose of these other medicines
Read More
diabetes drugs

BYETTA ® Exenatide

BYETTA ® a drug based on exenatide THERAPEUTIC GROUP: Other hypoglycemic agents excluding the various forms of insulin IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications BYETTA ® Exenatide BYETTA ® useful in the treatment of hyperglycemia of the second type diabetic patient not adequately controlled by taking oral hypoglycemic agents. F
Read More
diabetes drugs

Competact

What is Competact? Competact is presented as white oblong tablets containing two active substances, pioglitazone (15 mg) as hydrochloride and metformin hydrochloride (850 mg). What is Competact used for? Competact is used in patients (particularly those who are overweight) with non-insulin-dependent diabetes (type 2 diabetes)
Read More
diabetes drugs

COMPETACT ® - Pioglitazone + Metformin

COMPETACT ® a drug based on Pioglitazone hydrochloride and Metformin hydrochloride THERAPEUTIC GROUP: Oral hypoglycemic agents in association IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications COMPETACT ® - Pioglitazone + Metformin COMPETACT ® used in the treatment of hyperglycemia of the second type diabetic patient, in case of failure of therapy with metformin alone at the maximum tolerated doses. M
Read More